Effectiveness validated by clinical studies and peer reviewed publications:

J  ournal of Hospital infection, Elsevier Ltd., Prospective survey of indoor fungal contamination in hospital during a period of building construction, November 2007. 18 months prospective study in Dijon University Hospital Haematology unit during a period of construction. Infection Control and Hospital Epidemiology, The society of healthcare Epidemiology of America (SHEA), Decreasing Airbone Contamination Levels in High-Risk Hospital Areas Using a Novel Mobile Air-Treatment, October 2007. Study at Saint Antoine Hospital and University Hospital in Besanon involving operating room and pediatric hematology ward. J  ournal of Hospital Infection, Elsevier Ltd., Reduced Fungal contamination of the indoor environment with the Plasmair system (Airinspace), December 2006. Prospective study in Dijon University Hospital adult and pediatric hematology units. American Journal of Infection Control, The Association for Professionals in Infection Control (APIC), evaluation of new mobile system for protecting immune suppressed patients against airborne contamination, September 2007. 2 Studies at Necker Childrens Hospital, Paris, Immuno-Haematology Pediatric Service Department; and Rennes University Hospital, Rennes, France in the pediatric hematology wing.

plasmair

Sentinel

Hundreds of references in the healthcare sector

Copyright AirInSpace. All rights reserved. The information in this brochure are for reference only. Pictures are representative only. 1er trimestre 2012

Mobil air decontamination unit

Destroys airborne microorganisms: fungi, bacteria, viruses and spores Reduces gas and VOC molecules in the air to remove odours

airinspace SAS - Sige

Parc Technologique du Pas du Lac 10 avenue Ampre - Bt. B2 78180 Montigny le Bretonneux France Tel.: +33 (0) 1 30 07 01 01 Fax: +33 (0) 1 30 07 01 02 contact@airinspace.com

N ew

www.airinspace.com

Reduces infection risk in protected environments Reduces risk of aspergillosis

AIRINSPACE S.A.S. N TVA intracommunautaire FR 72442635561 Parc Technologique du Pas du Lac 10 avenue Ampre Bt. B2 78180 Montigny le Bretonneux France Tel.: +33 (0) 1 30 07 01 01 Fax: +33 (0) 1 30 07 01 02 contact@airinspace.com www.airinspace.com Socit au capital de 2.321.800 euros RCS Versailles 442 635 561 NAF 7219Z

Destroys micro-organisms Inactivation and destruction of microorganisms by the use of cold plasma. Validated efficiency against fungus, bacteria, viruses and spores. Microbiological reduction up 99,997% in one pass. Maintains reduction effeciency. Full compliance for use in High Risk 3 areas. Reduces the risk of infection. Plug and Play installation. Maintains airborne microbial level to B10 standards.

customer benefitS High performance. Mobility. Low sound effect. No space taken on the floor.  Investissment moderate or long time rent. Short installation time.  Easy installation requise limited maintenance.

Air decontamination  Aerodynamically optimized design of PlasmairTM.  Helps to prevent surface recontamination.  Rapid decontamination kinetcs.  Eliminates dead zones (contrained air).  Reduces ozone levels.

Performance Achieves required standards for use in a 35m3 Risk 3 room.  Target Objectives: ISO 7/B10 (<10 UFC/cm3) according to NF S 90 351 for risk zone 3. Rapid attainment of B10 levels (kinetics).

Example How the HEPA-MDTM Technology works  Based on a 35m room.  Starting contamination levels: ISO9.
3

Performance range Bacteriological class Particulate class Decontamination kinetics Dimensions Height Width Depth Weight Technical characteristics Max power consumption Noise levels at 1m 130 VA 400 m3/h 37 dB(A) 600 m3/h 41 dB(A) 850 m3/h 47 dB(A) 400 m3/h 35 dB(A) 600 m3/h 40 dB(A) 850 m3/h 46 dB(A) ~ 100 V/230 V 50Hz/60Hz 400-600-850 m3/h 150 cm 70 cm 45 cm 100 kg B100/B10 ISO8/ISO7 CP20/CP10

High performance filtration, microbial destruction and more

 Target objectives: ISO7/ CP20*.

* Time in minutes to achieve a 90% reduction from the contamination peak.

4 3 2 1

Module 1
Plasmerisation Microbial Destruction
TM

Module 2
Biological decontamination and HEPA particulate reduction Highly charged matter exiting the plasma chambers is caught by the electified active media. Organic material is then continually exposed to the plasma ions to ensure total biological decontamination.

Module 3
Molecular filtration Airborne molecular compounds are eliminated in the catalytic converter. This reconstitutes any remaining oxidants to enhance environmental levels.

Module 4
Molecular trapping Organic and mineral volatile molecular pollutants are absorbed into an activated carbon medium.

Destruction of microorganisms by exposure to strong electric fields which create oxidising species of air in the unique non-thermal plasma chambers.

Recognized and verified efficacy Technology validated by international research institutes: School of Public Health, Harvard University, Boston (United States), Health Protection Agency Porton Down, (United Kingdom), CNRS (France).

Noise levels at 2m Frequency and voltage Airflow range Regulatory

Elimination of risk associated with the storage and disposal of viable microorganisms. Reduction of VOCs (volatile organic compounds). Maintains high airflow through media, low noise, low power consumption.

CE marked Class 1 medical equipment According to EC Directive 93/42 EEC (1993) and the European Directive 2007/47 EC